E Fund Management Co., Ltd. - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
E Fund Management Co., Ltd. ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$253
-38.4%
26,982
+61.0%
0.02%
-40.6%
Q2 2023$411
+3.5%
16,762
-1.9%
0.03%
+10.3%
Q1 2023$397
-2.9%
17,081
+5.6%
0.03%
-14.7%
Q4 2022$409
-99.9%
16,178
-24.0%
0.03%
-10.5%
Q3 2022$410,000
-14.9%
21,284
+12.4%
0.04%
-13.6%
Q2 2022$482,000
+52.5%
18,939
+54.2%
0.04%
+340.0%
Q1 2022$316,00012,2830.01%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$36,281,23432.04%
SB INVESTMENT ADVISERS (UK) LTD 18,319,938$426,304,9573.50%
Zebra Capital Management LLC 27,110$6313.15%
Avidity Partners Management LP 1,640,200$38,167,4541.27%
Sofinnova Investments, Inc. 657,559$15,301,3980.98%
DCF Advisers, LLC 62,000$1,442,7400.88%
SECTOR GAMMA AS 145,545$3,386,8320.82%
Temasek Holdings (Private) Ltd 5,814,972$135,314,3980.80%
BRAIDWELL LP 604,036$14,055,9180.46%
SummerHaven Investment Management, LLC 26,045$606,0670.35%
View complete list of VIR BIOTECHNOLOGY INC shareholders